Skip to main content
. 2022 May 6;6(9):2884–2892. doi: 10.1182/bloodadvances.2021006623

Figure 2.

Figure 2.

Change of thrombin generation with use of tamoxifen and aromatase inhibitors. Box plots of the measures of ETP (A), thrombin peak (B), nAPCsr (C), and nTMsr at baseline and after 3 months in users of tamoxifen and in users of AIs (D). *P < .0041 (threshold of statistical significance).